GlySure Develops a Continuous Glucose Monitoring System
GlySure has developed an intravascular sensor capable of continuously monitoring a patient’s glucose for the length of their stay in the ICU.
GlySure has developed an intravascular sensor capable of continuously monitoring a patient’s glucose for the length of their stay in the ICU.
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
DATATRAK International, Inc. announced translation of DATATRAK ONE to Simplified Chinese
The Oppenheimer 22nd Annual Healthcare Conference will take place at the Waldorf=Astoria in New York City, December 13-14, 2011. This conference will present a core […]
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Results of a published prospective three-year clinical study have demonstrated that the Reducer is safe and effective at providing relief of angina symptoms in refractory angina patients.
Wound Management announced that its subsidiary, Resorbable Orthopedic Products has entered into an agreement with BioStructures.
IntelGenx is at the forefront of the industry with CPI-300 being the only single dose 450 mg formulation of Bupropion HCl approved by the FDA.
VisionCare’s lead product, Implantable Miniature Telescope by Dr. Isaac Liphitz, enlarges images in front of the eye approximately 2.5 times their normal size.
December 10-13, 2011 1:00 AM – 1:00 AM San Diego, CA 2011 Annual Meeting abstracts, final program, and personal scheduler The American Society of Hematology […]
Copyright © 2025 | WordPress Theme by MH Themes